Publications of A. Visekruna

Journal Article (13)

2015
Journal Article
Visekruna, A.; Linnerz, T.; Martinic, V.; Vachharajani, N.; Hartmann, S.; Harb, H.; Joeris, T.; Pfefferle, P.I.; Hofer, M. J.; Steinhoff, U.: Transcription factor c-Rel plays a crucial role in driving anti-CD40-mediated innate colitis. Mucosal Immunology 8 (2), pp. 307 - 315 (2015)
2012
Journal Article
Joeris, T.; Schmidt, N.; Ermert, D.; Krienke, P.; Visekruna, A.; Kuckelkorn, U.; Kaufmann, S. H. E.; Steinhoff, U.: The Proteasome System in Infection: Impact of beta 5 and LMP7 on Composition, Maturation and Quantity of Active Proteasome Complexes. PLoS ONE 7 (6), e39827 (2012)
Journal Article
Joeris, T.; Schmidt, N.; Ermert, D.; Krienke, P.; Visekruna, A.; Kuckelkorn, U.; Kaufmann, S. H. E.; Steinhoff, U.: The Proteasome System in Infection: Impact of beta 5 and LMP7 on Composition, Maturation and Quantity of Active Proteasome Complexes. PLoS ONE 7 (6), e39827 (2012)
Journal Article
Lawrenz, M.; Visekruna, A.; Kuhl, A.; Schmidt, N.; Kaufmann, S. H. E.; Steinhoff, U.: Genetic and pharmacological targeting of TPL-2 kinase ameliorates experimental colitis: a potential target for the treatment of Crohn's disease. Mucosal Immunology 5 (2), pp. 129 - 139 (2012)
Journal Article
Visekruna, A.; Volkov, A.; Steinhoff, U.: A Key Role for NF-kappa B Transcription Factor c-Rel in T-Lymphocyte-Differentiation and Effector Functions. CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 239368 (2012)
2011
Journal Article
Reinhard, K.; Huber, M.; Wostl, C.; Hellhund, A.; Toboldt, A.; Abass, E.; Casper, B.; Joeris, T.; Herr, C.; Bals, R. et al.; Steinhoff, U.; Lohoff, M.; Visekruna, A.: c-Rel promotes type 1 and type 17 immune responses during Leishmania major infection. European Journal of Immunology 41 (5), pp. 1388 - 1398 (2011)
2010
Journal Article
Schmidt, N.; Gonzalez, E.; Visekruna, A.; Kühl, A. A.; Loddenkemper, C.; Mollenkopf, H. J.; Kaufmann, S. H. E.; Steinhoff, U.; Joeris, T.: Targeting the proteasome: partial inhibition of the proteasome by bortezomib or deletion of the immunosubunit LMP7 attenuates experimental colitis. Gut 59 (7), pp. 896 - 906 (2010)
Journal Article
Visekruna, A.; Huber, M.; Hellhund, A.; Bothur, E.; Reinhard, K.; Bollig, N.; Schmidt, N.; Joeris, T.; Lohoff, M.; Steinhoff, U.: c-Rel is crucial for the induction of Foxp3(+) regulatory CD4(+) T cells but not T(H)17 cells. European Journal of Immunology 40 (3), pp. 671 - 676 (2010)
Journal Article
Lauscher, J. C.; Gröne, J.; Dullat, S.; Hotz, B.; Ritz, J.-P.; Steinhoff, U.; Buhr, H.-J.; Visekruna, A.: Association Between Activation of Atypical NF-kappa B1 p105 Signaling Pathway and Nuclear beta-Catenin Accumulation in Colorectal Carcinoma. Molecular Carcinogenesis 49 (2), pp. 121 - 129 (2010)
2009
Journal Article
Visekruna, A.; Slavova, N.; Dullat, S.; Gröne, J.; Kroesen, A.-J.; Ritz, J.-P.; Buhr, H.-J.; Steinhoff, U.: Expression of catalytic proteasome subunits in the gut of patients with Crohn's disease. International Journal of Colorectal Disease 24 (10), pp. 1133 - 1139 (2009)
Journal Article
Visekruna, A.; Joeris, T.; Schmidt, N.; Lawrenz, M.; Ritz, J.-P.; Buhr, H. J.; Steinhoff, U.: Comparative Expression Analysis and Characterization of 20S Proteasomes in Human Intestinal Tissues: The Proteasome Pattern as Diagnostic Tool for IBD Patients. Inflammatory Bowel Diseases 15 (4), pp. 526 - 533 (2009)
2006
Journal Article
Visekruna, A.; Joeris, T.; Seidel, D.; Kroesen, A.; Loddenkemper, C.; Zeitz, M.; Kaufmann, S. H. E.; Schmidt-Ullrich, R.; Steinhoff, U.: Proteasome-mediated degradation of I{kappa}B{alpha} and processing of p105 in Crohn disease and ulcerative colitis. Journal of Clinical Investigation 116 (12), pp. 3195 - 3203 (2006)
Journal Article
Strehl, B.; Joeris, T.; Rieger, M.; Visekruna, A.; Textoris-Taube, K.; Kaufmann, S. H. E.; Kloetzel, P.-M.; Kuckelkorn, U.; Steinhoff, U.: Immunoproteasomes are essential for clearance of Listeria monocytogenes in nonlymphoid tissues but not for induction of bacteria-specific CD8(+) T cells. Journal of Immunology 177 (9), pp. 6238 - 6244 (2006)
Go to Editor View